Ben Arye Barak - Jul 5, 2022 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
General Counsel
Signature
By: /s/ Steven Robbins, Attorney in Fact for Barak Ben Arye
Stock symbol
NVCR
Transactions as of
Jul 5, 2022
Transactions value $
$8,507
Form type
4
Date filed
7/7/2022, 05:50 PM
Previous filing
Apr 14, 2022
Next filing
Jan 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Award $8.51K +144 +0.85% $59.08 17K Jul 5, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2022 through June 30, 2022. This transaction is also exempt under Rule 16b-3(c).
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on June 30, 2022.